The cost of each comparator was obtained by calculating an average cost of treatment for the class of antibiotic weighted by the volume of claims reimbursed by the ODBP as reported by Pharmastat data (Table 1).
Reimbursement of fosfomycin by the ODBP would allow physicians to effectively treat patients with uUTIs while ensuring that community resistance to important antibiotics (fluoroquinolones and sulfonamides) is not further increased in Ontario.
* On May 15, lowering the generic prescription drug reimbursement by the ODBP by 50% to 25% of the original brand product price.
* Changing the permitted markup under the ODBP for rural pharmacies and those in underserviced areas from 8 % to 10%.
* Increasing the dispensing fee under the ODBP from $7 to $8 for most pharmacies and from $7 to between $9 and $11 for rural pharmacies and those in underserved areas.